Niche preclinical Farmington Pharma Development offers specialized preclinical development consulting and contract lab services to biotechs, pharma, and VC firms, suggesting a sales opportunity to target early-stage and portfolio-driven clients needing diligence, gap analysis, and program management.

Rare disease focus Experience supporting rare disease drug development programs indicates potential to engage sponsors seeking specialized nonclinical support and program management for high-value, regulatory-sensitive assets.

Small team, niche focus With a lean headcount and revenue in the lower multi-millions, Farmington presents an opportunity to upsell high-margin, repeatable services to larger contract labs or CROs seeking flexible, boutique capabilities as a turnkey extension.

Strategic partnerships Position Farmington as a complementary or specialty provider within larger CRO networks by offering targeted diligence, gap analysis, and nonclinical development expertise to augment big-partner capabilities.

Portfolios and diligence Target venture-backed and portfolio companies in need of efficient nonclinical diligence and program management to accelerate funding rounds or milestones, leveraging Farmington’s proven track record in preclinical development assessments.